Skip to content

Autocomp

by Victoreen, Inc.

510(k) K911340

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK911340 Date26 Aug 1991ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
KPQ
Device Class
Class II
Regulation
21 CFR Part 892.5840
Advisory Committee
Radiology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Autocomp is a System, Simulation, Radiation Therapy Device designed for use in radiology. It is intended to assist in the precise delivery and verification of radiation therapy by simulating treatment planning and dose calculations, ensuring accurate patient-specific dose distributions.

This device is supplied as a reusable system and is regulated under FDA 510(k) clearance (K911340), classified as a Class II medical device. It operates in radiology settings and adheres to regulatory standards for radiation therapy simulation systems, with no specific sterility requirements noted in the data. The device is authorized for use in the United States and is governed by FDA guidelines for radiation therapy equipment.

Other devices from Victoreen, Inc.

See all devices from Victoreen, Inc. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of the Autocomp in a radiology setting?

    The Autocomp is designed to assist radiology teams in delivering precise radiation therapy by simulating treatment planning and performing dose calculations. This helps ensure accurate, patient-specific dose distributions, improving the reliability of radiation treatment delivery.

  • Is the Autocomp intended for single-use or reusable applications?

    The Autocomp is supplied as a reusable system, meaning it is built for repeated use in clinical settings rather than disposable after a single application. This aligns with its classification as a Class II medical device under FDA guidelines.

  • What regulatory pathway does the Autocomp follow, and where is it authorized for use?

    The Autocomp is authorized for use in the United States through FDA clearance via a 510(k) submission (K911340), classified as a Class II device. It adheres to FDA standards for radiation therapy simulation systems and is governed by regulatory requirements specific to radiology equipment.

  • Does the Autocomp require sterilization before use, and if so, what are the guidelines?

    The Autocomp is not described as requiring sterility in its specifications, as it is a reusable system designed for use in controlled radiology environments rather than direct patient contact. However, standard infection control practices should still be followed during maintenance and cleaning.

  • How is the Autocomp categorized in terms of medical specialty and device classification?

    The Autocomp is classified under Radiology as its medical specialty and falls under OpenFDA device classification 2 (Class II). It is specifically listed under the product code KPQ, which corresponds to radiation therapy simulation systems, ensuring it meets regulatory standards for that category.